Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daphna Levy

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Plos One|April 17, 2012
Activation of cell cycle arrest and apoptosis by the proto-oncogene Pim-2Daphna Levy, Ateret Davidovich, Shahar Zirkin, et al.
Immunotherapy|December 22, 2012
Adoptive T-cell transfer in melanomaOrit Itzhaki, Daphna Levy, Dragoslav Zikich, et al.
Cancer Immunology, Immunotherapy : CII|March 24, 2012
CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapySivan Sapoznik, Rona Ortenberg, Gilli Galore-Haskel, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 10, 2011
Establishment and large-scale expansion of minimally cultured "young" tumor infiltrating lymphocytes for adoptive transfer therapyOrit Itzhaki, Einat Hovav, Yaara Ziporen, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 2, 2013
A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot studyEyal Greenberg, Michal J Besser, Eytan Ben-Ami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2010
Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patientsMichal J Besser, Ronnie Shapira-Frommer, Avraham J Treves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2013
Adoptive transfer of tumor-infiltrating lymphocytes in patients with metastatic melanoma: intent-to-treat analysis and efficacy after failure to prior immunotherapiesMichal J Besser, Ronnie Shapira-Frommer, Orit Itzhaki, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Plos One|April 17, 2012
Activation of cell cycle arrest and apoptosis by the proto-oncogene Pim-2Daphna Levy, Ateret Davidovich, Shahar Zirkin, et al.
Immunotherapy|December 22, 2012
Adoptive T-cell transfer in melanomaOrit Itzhaki, Daphna Levy, Dragoslav Zikich, et al.
Cancer Immunology, Immunotherapy : CII|March 24, 2012
CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapySivan Sapoznik, Rona Ortenberg, Gilli Galore-Haskel, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 10, 2011
Establishment and large-scale expansion of minimally cultured "young" tumor infiltrating lymphocytes for adoptive transfer therapyOrit Itzhaki, Einat Hovav, Yaara Ziporen, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 2, 2013
A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot studyEyal Greenberg, Michal J Besser, Eytan Ben-Ami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2010
Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patientsMichal J Besser, Ronnie Shapira-Frommer, Avraham J Treves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2013
Adoptive transfer of tumor-infiltrating lymphocytes in patients with metastatic melanoma: intent-to-treat analysis and efficacy after failure to prior immunotherapiesMichal J Besser, Ronnie Shapira-Frommer, Orit Itzhaki, et al.
Pageof 1